Medifast Inc. | Micro-cap | Consumer Cyclical
$14.67
4.41%
| Medifast Stock Comparison:
Medifast vs RollinsMedifast vs ServiceMedifast vs RegisMedifast vs Yy Group HoldingMedifast vs WW InternationalMedifast vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 602.5M
Gross Profit 444.6M 73.80%
Operating Income 2.9M 0.48%
Net Income 2.1M 0.35%
EPS (Diluted) $0.19

Balance Sheet Metrics

Total Assets 284.2M
Total Liabilities 74.1M
Shareholders Equity 210.1M
Debt to Equity 0.35

Cash Flow Metrics

Operating Cash Flow 18.7M
Free Cash Flow 17.0M

Revenue & Profitability Trend

Medifast Income Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Revenue 602.5M 1.1B 1.6B 1.5B 934.8M
Cost of Goods Sold 157.8M 296.2M 458.2M 398.5M 237.0M
Gross Profit 444.6M 775.8M 1.1B 1.1B 697.8M
Research & Development - - - - -
Selling, General & Administrative 441.7M 649.4M 955.6M 911.4M 563.7M
Other Operating Expenses 0 0 0 0 0
Total Operating Expenses 441.7M 649.4M 955.6M 911.4M 563.7M
Operating Income 2.9M 126.4M 184.8M 216.2M 134.2M
Pre-tax Income 3.8M 128.8M 184.1M 216.1M 134.3M
Income Tax 1.7M 29.4M 40.5M 52.1M 31.4M
Net Income 2.1M 99.4M 143.6M 164.0M 102.9M
EPS (Diluted) $0.19 $9.10 $12.73 $13.89 $8.68

Income Statement Trend

Medifast Balance Sheet From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Assets
Current Assets 214.4M 224.0M 222.8M 306.9M 234.3M
Non-Current Assets 69.8M 85.9M 93.4M 91.5M 41.8M
Total Assets 284.2M 309.9M 316.2M 398.3M 276.1M
Liabilities
Current Liabilities 64.2M 92.3M 140.9M 169.8M 111.4M
Non-Current Liabilities 9.9M 16.1M 20.3M 26.0M 7.5M
Total Liabilities 74.1M 108.4M 161.2M 195.9M 118.8M
Equity
Total Shareholders Equity 210.1M 201.5M 155.0M 202.5M 157.2M

Balance Sheet Composition

Medifast Cash Flow Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Operating Activities
Net Income 2.1M 99.4M 143.6M 164.0M 102.9M
Operating Cash Flow 18.7M 141.2M 192.3M 50.0M 115.9M
Investing Activities
Capital Expenditures -7.5M -6.5M -16.7M -34.2M -5.9M
Investing Cash Flow -26.5M -61.0M -11.4M -29.1M -1.3M
Financing Activities
Dividends Paid -715.0K -73.0M -71.6M -63.9M -53.2M
Financing Cash Flow -1.6M -80.0M -199.6M -125.9M -58.7M
Free Cash Flow 17.0M 141.2M 177.9M 60.3M 139.3M

Cash Flow Trend

Medifast Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 63.89
Forward P/E 44.37
Price to Book 0.65
Price to Sales 0.27
PEG Ratio 44.37

Profitability Ratios

Profit Margin -1.29%
Operating Margin -1.09%
Return on Equity -3.32%
Return on Assets 1.33%

Financial Health

Current Ratio 3.52
Debt to Equity 6.93
Beta 0.89

Per Share Data

EPS (TTM) -$0.64
Book Value per Share $20.40
Revenue per Share $49.68

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
med 146.3M 63.89 0.65 -3.32% -1.29% 6.93
Rollins 27.7B 57.71 20.42 37.83% 13.78% 67.20
Service 11.3B 21.94 6.89 32.72% 12.58% 292.19
Regis 50.5M 0.55 0.74 548.07% 49.34% 535.95
Yy Group Holding 89.1M 20.23 13.70 -93.74% -11.77% 81.32
WW International 20.0M -0.07 -0.02 31.02% -9.19% -1.40

Financial data is updated regularly. All figures are in the company's reporting currency.